Mechanism for the transcriptional repression by c-Myc on PDGF β-receptor

Journal of Cell Science

Volumn 114, Issue 8, 2001, Pages 1533-1544

  Izumi, Hiroto ^a   Molander, Catrin ^a   Penn, Linda Z ^c   Ishisaki, Akira ^d   Kohno, Kimitoshi ^b   Funa, Keiko ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

^d NATL INST BIOSCI HUM TECHNOL   (Japan)

Author keywords

receptor; C Myc; NF Y; Platelet derived growth factor; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; DNA; DNA BINDING PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; LUCIFERASE; MESSENGER RNA; MYC PROTEIN; NUCLEAR FACTOR; NUCLEAR FACTOR Y; NUCLEAR FACTOR YA; NUCLEAR FACTOR YB; NUCLEAR FACTOR YC; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL STRAIN 3T3; CELL STRAIN COS1; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA BINDING; GENE ACTIVATION; GENE ACTIVITY; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; REPORTER GENE; RNA TRANSLATION; SEQUENCE HOMOLOGY;

3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CARRIER PROTEINS; CCAAT-BINDING FACTOR; COS CELLS; DNA-BINDING PROTEINS; HUMANS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0035014553     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Alevizopoulos, K., Vlach, J., Hennecke, S. and Amati, B. (1997). Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16, 5322-5333.
2. Ayer, D. E., Kretzner, L., Eisenman, R. N. (1993). Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222.
3. Ballagi, A. E., Ishizaki, A., Nehlin, J. O. and Funa, K. (1995). Isolation and characterization of the mouse PDGF beta-receptor promoter. Biochem. Biophys. Res. Commun. 210, 165-173.
4. Bao, J. and Zervos, A. S. (1996). Isolation and characterization of Nmi, a novel partner of Myc proteins. Oncogene 12, 2171-2176.
5. Bellorini, M., Lee, D. K., Dantonel, J. C., Zemzoumi, K., Roeder, R. G., Tora, L. and Mantovani, R. (1997a). CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res. 25, 2174-2181.
6. Bellorini, M., Zemzoumi, K., Farina, A., Berthelsen, J., Piaggio, G. and Mantovani, R. (1997b). Cloning and expression of human NF-YC. Gene 193, 119-125.
7. 1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15, 1347-1356.
8. Bolognese, F., Wasner, M., Dohna, C. L., Gurtner, A., Ronchi, A., Muller, H., Manni, I., Mossner, J., Piaggio, G., Mantovani, R. et al. (1999). The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene 18, 1845-1853.
9. Bowen-Pope, D. F., Vogel, A. and Ross, R. (1984). Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc. Natl. Acad. Sci. USA 81, 2396-2400.
10. Facchini, L. M., Chen, S., Marhin, W. W., Lear, J. N. and Penn, L. Z. (1997). The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17, 100-114.
11. Gaubatz, S., Imhof, A., Dosch, R., Werner, O., Mitchell, P., Buettner, R. and Eilers, M. (1995). Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14, 1508-1519.
12. Grolendorst, G. R. (1984). Alteration of the chemotactic response of NIH/3T3 cells to PDGF by growth factors, transformation, and tumor promoters. Cell 36, 279-285.
13. Gu, W., Bhatia, K., Magrath, I. T., Dang, C. V. and Dalla-Favera, R. (1994). Binding and suppression of the Myc transcriptional activation domain by p 107. Science 264, 251-254.
14. Heldin, C. H., Ostman, A. and Ronnstrand, L. (1998). Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta 1378, F79-113.
15. Heldin, C. H. and Westermark, B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316.
16. Ishisaki, A., Murayama, T., Ballagi, A. E. and Funa, K. (1997). Nuclear factor Y controls the basal transcription activity of the mouse platelet-derived-growth-factor beta-receptor gene. Eur. J. Biochem. 246, 142-146.
17. Izumi, H., Ono, M., Ushiro, S., Kohno, K., Kung, H. F. and Kuwano, M. (1994). Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells. Exp. Cell Res. 214, 654-662.